Founding CEO John McKearn, Ph.D. is all-in on the pursuit of lower-cost, off-the-shelf, allogeneic CAR T-cell therapies to address a host of oncological indications. Dr. John McKearn is an academic and research scientist turned biotech entrepreneur and venture capitalist. His latest venture, Wugen, is a private, preclinical biopharma taking a novel approach to developing off-the-shelf […]

Psychiatry is an area that Jonathan Javitt never planned to work in. In fact, he still jokes that he flunked a psychiatry class while in medical school. Unfortunately, life has a way of changing your focus. For Javitt, who is now the co-founder and CEO of NeuroRx, that happened 11 years ago when one of […]

NeuroRX has a history of pursuing treatments for illnesses abandoned by others. Their latest drug had been shelved for 20 years until they unearthed it this March. Jonathan Javitt and his younger brother Daniel Javitt took different paths early in their medical careers. Jonathan Javitt started out in ophthalmology and later found himself in healthcare […]